Clinical Trial Update: SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding [Phase 2]

View source ↗

Summary

Phase 2 dose tolerability/dose-range finding study of SUBLIVAC FIX Birch has completed, evaluating tolerability across multiple doses in allergic rhinitis and a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinoconjunctivitis

Drugs mentioned

• SUBLIVAC FIX Birch (birch pollen allergen extract)

Snippet

Sponsor: HAL Allergy | Conditions: Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 2 | Status: COMPLETED